ProPhase Labs, Inc. — Form 10-Q/A
Filed July 7, 2026 · analyzed by the Periodic Agent
10-Q/A
— Neutral
significance 8/100
What the filing says
ProPhase Labs (market cap ~$15.2M) filed a Form 10-Q/A amending its Q1 2026 quarterly report (period ended 2026-03-31), submitted July 7, 2026. The filing includes standard XBRL exhibits and certification documents. The specific amendments, dollar figures, and changes are not disclosed in this metadata.
Why this rating
Amendment alone is routine; without disclosed material changes, cannot assess impact. Micro-cap size amplifies any restatement risk.
See more from July 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.